Abstract: Damping arrangement for an axle of an active chassis of a motor vehicle. A damping system interacts with each wheel of the axle. Each of the damping systems includes the following assemblies: a damper including a double-acting hydraulic cylinder and a piston, a hydraulic pump and an electric motor for driving same, and a hydraulic unit which includes a hydraulic reservoir and valves. The hydraulic pump and the hydraulic unit of the respective damping system interact with hydraulic chambers of the hydraulic cylinder in such a manner that a movement of the piston in a first or in a second operating direction can be provided depending on the delivery direction of the hydraulic pump. The electric motors of both damping systems are connected to a common control device and can be actuated thereby, wherein the common control device has electronic assemblies which are distributed on different printed circuit boards.

Abstract: A high-voltage component of an electric vehicle, which high-voltage component can be connected to a high-voltage traction battery of the electric vehicle. The high-voltage component includes at least one electric machine; a power electronic assembly which is configured to convert the high voltage of the traction battery into an operating voltage for the electric machine; and a control assembly which can be connected to a low-voltage on-board electrical system of the electric vehicle. The control assembly includes a control unit which is configured to control the operation of the high-voltage component. The power electronic assembly has an integrated DC-DC voltage converter which is connected to the control assembly and which is designed to convert the high voltage of the traction battery into a voltage corresponding to the voltage of the low-voltage on-board electrical system of the electric vehicle.

Abstract: A damping arrangement for an axle of an active chassis of a motor vehicle. A damping system interacts with each wheel of the axle, each damping system has the following: a damper having a double-acting hydraulic cylinder and a piston, a hydraulic pump and an electric motor for driving the hydraulic pump, a hydraulic unit having a hydraulic reservoir and valves. The hydraulic pump and the hydraulic unit of the respective damping system interact with the respective hydraulic cylinder in such a manner that, depending on the conveyance direction of the hydraulic pump, a movement of the piston can be provided in a first or in a second actuation direction. The electric motors of both damping systems are arranged with axially aligned rotational axes in a casing and can be regulated by a common control device which has electronic construction groups which are arranged on at least one circuit board.

Abstract: Damping arrangement for an axle of an active chassis of a motor vehicle. A damping system interacts with each wheel of the axle. Each of the damping systems includes the following assemblies: a damper including a double-acting hydraulic cylinder and a piston, a hydraulic pump and an electric motor for driving same, and a hydraulic unit which includes a hydraulic reservoir and valves. The hydraulic pump and the hydraulic unit of the respective damping system interact with hydraulic chambers of the hydraulic cylinder in such a manner that a movement of the piston in a first or in a second operating direction can be provided depending on the delivery direction of the hydraulic pump. The electric motors of both damping systems are connected to a common control device and can be actuated thereby, wherein the common control device has electronic assemblies which are distributed on different printed circuit boards.

Abstract: A method of treating a patient who has prostate cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize cells in the patient that aberrantly express a peptide. A pharmaceutical composition contains activated T cells that selectively recognize cells in a patient that aberrantly express a peptide, and a pharmaceutically acceptable carrier, in which the T cells bind to the peptide in a complex with an MHC class I molecule, and the composition is for treating the patient who has prostate cancer. A method of treating a patient who has prostate cancer includes administering to said patient a composition comprising a peptide in the form of a pharmaceutically acceptable salt, thereby inducing a T-cell response to the prostate cancer.

Abstract: A method of treating a patient who has prostate cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize cells in the patient that aberrantly express a peptide. A pharmaceutical composition contains activated T cells that selectively recognize cells in a patient that aberrantly express a peptide, and a pharmaceutically acceptable carrier, in which the T cells bind to the peptide in a complex with an MHC class I molecule, and the composition is for treating the patient who has prostate cancer. A method of treating a patient who has prostate cancer includes administering to said patient a composition comprising a peptide in the form of a pharmaceutically acceptable salt, thereby inducing a T-cell response to the prostate cancer.

Abstract: A method of treating a patient who has prostate cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize cells in the patient that aberrantly express a peptide. A pharmaceutical composition contains activated T cells that selectively recognize cells in a patient that aberrantly express a peptide, and a pharmaceutically acceptable carrier, in which the T cells bind to the peptide in a complex with an MHC class I molecule, and the composition is for treating the patient who has prostate cancer. A method of treating a patient who has prostate cancer includes administering to said patient a composition comprising a peptide in the form of a pharmaceutically acceptable salt, thereby inducing a T-cell response to the prostate cancer.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: A method of treating a patient who has prostate cancer includes administering to said patient a composition containing a population of activated T cells that selectively recognize cells in the patient that aberrantly express a peptide. A pharmaceutical composition contains activated T cells that selectively recognize cells in a patient that aberrantly express a peptide, and a pharmaceutically acceptable carrier, in which the T cells bind to the peptide in a complex with an MHC class I molecule, and the composition is for treating the patient who has prostate cancer. A method of treating a patient who has prostate cancer includes administering to said patient a composition comprising a peptide in the form of a pharmaceutically acceptable salt, thereby inducing a T-cell response to the prostate cancer.

Abstract: An object is provided with a label for identifying in a cable-less manner by an electromagnetic radiation. The inventive label comprises at least one antenna receiving an incident electromagnetic signal and characterized reducing the influence of dispersion or straying capacities caused by the object on file remnant properties of the label. Such that the label can be applied to any object, particularly optical or magneto-optical data carriers.

Abstract: Disclosed is a label for identifying in a cableless manner, by means of electromagnetic radiation, an object which is provided with said label. The inventive label comprises at least one antenna receiving an incident electromagnetic signal and means reducing the influence of dispersion capacities caused by the object on the resonant properties of the label such that the label can be applied to any object, particularly optical or magneto-optical data carriers.